Innate Pharma
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
330 disclosures on record
Evolution of the disclosed total
0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
April 15, 2014 today
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| June 12, 2017 | Millennium International Management LP | 0.51% | June 20, 2017 |
| June 9, 2017 | Marshall Wace LLP | 1.61% | January 4, 2018 |
| June 9, 2017 | Millennium International Management LP | 0.48% | June 13, 2017 |
| June 7, 2017 | Millennium International Management LP | 0.52% | June 13, 2017 |
| June 6, 2017 | Citadel Advisors II LLC | 0.51% | June 26, 2017 |
| May 31, 2017 | Marshall Wace LLP | 1.51% | January 4, 2018 |
| May 26, 2017 | Marshall Wace LLP | 1.40% | January 4, 2018 |
| May 18, 2017 | Citadel Advisors II LLC | 0.47% | May 22, 2017 |
| May 16, 2017 | Oxford Asset Management LLP | 0.59% | September 19, 2017 |
| May 11, 2017 | Marshall Wace LLP | 1.31% | January 4, 2018 |
| May 9, 2017 | Marshall Wace LLP | 1.21% | January 4, 2018 |
| May 5, 2017 | Marshall Wace LLP | 1.16% | January 4, 2018 |
| May 3, 2017 | Worldquant, LLC | 0.45% | May 5, 2017 |
| April 27, 2017 | Worldquant, LLC | 0.58% | May 5, 2017 |
| April 27, 2017 | GSA Capital Partners LLP | 0.48% | May 2, 2017 |
| April 25, 2017 | Marshall Wace LLP | 1.09% | January 4, 2018 |
| April 24, 2017 | Oxford Asset Management LLP | 0.68% | September 19, 2017 |
| April 21, 2017 | GSA Capital Partners LLP | 0.58% | May 2, 2017 |
| April 13, 2017 | Marshall Wace LLP | 1.19% | January 4, 2018 |
| April 12, 2017 | Worldquant, LLC | 0.69% | May 5, 2017 |
| April 7, 2017 | Worldquant, LLC | 0.76% | May 5, 2017 |
| April 6, 2017 | GSA Capital Partners LLP | 0.69% | May 2, 2017 |
| April 4, 2017 | Marshall Wace LLP | 1.21% | January 4, 2018 |
| March 30, 2017 | GSA Capital Partners LLP | 0.79% | May 2, 2017 |
| March 29, 2017 | Worldquant, LLC | 0.82% | May 5, 2017 |
| March 27, 2017 | Marshall Wace LLP | 1.11% | January 4, 2018 |
| March 22, 2017 | Marshall Wace LLP | 1.00% | January 4, 2018 |
| March 22, 2017 | Worldquant, LLC | 0.73% | May 5, 2017 |
| March 21, 2017 | Oxford Asset Management LLP | 0.72% | September 19, 2017 |
| March 17, 2017 | Marshall Wace LLP | 0.90% | January 4, 2018 |
| March 17, 2017 | Worldquant, LLC | 0.60% | May 5, 2017 |
| March 16, 2017 | Marshall Wace LLP | 0.86% | January 4, 2018 |
| March 15, 2017 | GSA Capital Partners LLP | 0.81% | May 2, 2017 |
| March 15, 2017 | Worldquant, LLC | 0.54% | May 5, 2017 |
| March 14, 2017 | Marshall Wace LLP | 0.70% | January 4, 2018 |
| March 14, 2017 | Oxford Asset Management LLP | 0.60% | September 19, 2017 |
| March 13, 2017 | GSA Capital Partners LLP | 0.79% | May 2, 2017 |
| March 10, 2017 | Great Point Partners, LLC | 0.41% | March 13, 2017 |
| March 9, 2017 | Citadel Advisors II LLC | 0.53% | May 22, 2017 |
| March 9, 2017 | Oxford Asset Management LLP | 0.50% | September 19, 2017 |
| March 8, 2017 | GSA Capital Partners LLP | 0.82% | May 2, 2017 |
| March 7, 2017 | Marshall Wace LLP | 0.64% | January 4, 2018 |
| March 6, 2017 | Marshall Wace LLP | 0.79% | January 4, 2018 |
| March 2, 2017 | Great Point Partners, LLC | 0.57% | March 13, 2017 |
| March 1, 2017 | Marshall Wace LLP | 0.89% | January 4, 2018 |
| February 28, 2017 | Marshall Wace LLP | 0.96% | January 4, 2018 |
| February 23, 2017 | GSA Capital Partners LLP | 0.70% | May 2, 2017 |
| February 23, 2017 | Great Point Partners, LLC | 0.69% | March 13, 2017 |
| February 22, 2017 | GSA Capital Partners LLP | 0.69% | May 2, 2017 |
| February 21, 2017 | GSA Capital Partners LLP | 0.70% | May 2, 2017 |
Other companies sold short in France
- Ubisoft Entertainment 13.90% of the capital sold short
- Valeo 10.92% of the capital sold short
- Teleperformance 8.94% of the capital sold short
- Renault 6.44% of the capital sold short
- FDJ United 6.17% of the capital sold short
- Remy Cointreau 5.36% of the capital sold short
- Viridien 5.25% of the capital sold short
- Alstom 5.23% of the capital sold short
- Abivax 5.04% of the capital sold short
- Worldline 4.48% of the capital sold short
- Vusiongroup 4.08% of the capital sold short
- Forvia 4.06% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Innate Pharma, source AMF, data as at January 28, 2022, https://www.quivad.com/action/innate-pharma?page=3